Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/12/2019
SIETES contiene 92850 citas

 
 
 1 a 15 de 15 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Kloprogge F, Workman L, Bormann S, Tékété M, Lefèvre G, Hamed K, Piola P, Ursing J, Kofoed PE, Martensson A, Ngasala B, Björkman A, Ashton M, Hietala SF, Aweeka F, Parikh S, Mwai L, Davis TME, Karunajeewa H, Salman S, Checchi F, Fogg C, Newton PN, Mayxay M, Deloron P, Faucher JF, Nosten F, Ashley EA, McGready R, van Vugt M, Proux S, Price RN, Karbwang J, Ezzet F, Bakshi R, Stepniewska K, White NJ, Guerin PJ, Bames KI, Tarning J. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis. PLOS Medicine 2018:12 de junio. [Ref.ID 102769]
2.Tiene citas relacionadas Cita con resumen
Jha TK, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, Voss A, Berman J. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 1999;341:1795-800. [Ref.ID 48040]
3.
Honrado ER, Fungladda W, Kamoiratanaku P, Kitayaporn D, Karbwang J, Thimasarn K, Masngammueng R. Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand. Bulletin of the World Health Organization 1999;77:235-43. [Ref.ID 43792]
4.
Ezzet F, Mull R, Karbwang J. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol 1998;46:553-61. [Ref.ID 41460]
5.
Karbwang J, Na-Bangchang K, Tin T, Sukontason K, Rimchala W, Harinasuta T. Pharmacokinetics of intramuscular artemether in patients with severe Falciparum malaria with or without acute renal failure. Br J Clin Pharmacol 1998;45:597-600. [Ref.ID 38712]
6.
Karbwang J, Na-Bangchang K, Congpoung K, Thanavibul A, Harinasuta T. Pharmacokinetics of oral artesunate in Thai patients with uncomplicated falciparum malaria. Clin Drug Invest 1998;15:37-43. [Ref.ID 36958]
7.
Na-Bangchang K, Karbwang J, Congpoung K, Thanavibul A, Ubalee R. Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate. Eur J Clin Pharmacol 1998;53:375-6. [Ref.ID 36945]
8.
Karbwang J, Na-Bangchang K, Congpuong K, Molunto P, Thanavibul A. Pharmacokinetics and bioavailability of oral and intramuscular artemether. Eur J Clin Pharmacol 1997;52:307-10. [Ref.ID 33634]
9. Cita con resumen
Karbwang J, Na-Bangchang K, Thanavibul A, Ditta-In M, Bunnag D, Harinasuta T. Comparative clinical trial of artesunate and the combination of artesunate-mefloquine in multidrug-resistant Falciparum malaria. Clin Drug Invest 1996;11:84-9. [Ref.ID 26049]
10.
Karbwang J, Bangchang KN. Clinical pharmacokinetics of halofantrine. Clin Pharmacokinet 1994;27:104-19. [Ref.ID 22429]
11.
Bangchang KN, Karbwang J, Thomas CG, Thanavibul A, Sukontason K, Ward SA, Edwards G. Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated Falciparum malaria. Br J Clin Pharmacol 1994;37:249-53. [Ref.ID 21415]
12. Cita con resumen
Karbwang J, Banchang KN, Thanavibull A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet 1992;340:1245-8. [Ref.ID 18361]
13.
Karbwang J, White NJ. Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 1990;19:264-79. [Ref.ID 14044]
14.
Phillips R E, Warrell DA, White NJ, Looaresuwan S, Karbwang J. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med 1985;312:1273-8. [Ref.ID 9129]
15.
Looaresuwan S, Phillips R E, White NJ, Karbwang J, Benjasurat Y, Attanath P, Warrell DA. Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria. Lancet 1985;2:805-8. [Ref.ID 8869]
Seleccionar todas
 
 1 a 15 de 15